Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | SMMT |
---|---|---|
09:32 ET | 34502 | 18.54 |
09:34 ET | 13556 | 18.7185 |
09:36 ET | 11654 | 18.895 |
09:38 ET | 10894 | 18.91 |
09:39 ET | 14507 | 19.14 |
09:41 ET | 25660 | 19.1768 |
09:43 ET | 38691 | 19.1509 |
09:45 ET | 11519 | 19.21 |
09:48 ET | 7033 | 19.1 |
09:50 ET | 25689 | 18.8125 |
09:52 ET | 12457 | 18.99 |
09:54 ET | 14467 | 18.876 |
09:56 ET | 9082 | 18.8501 |
09:57 ET | 6352 | 18.93 |
09:59 ET | 7940 | 18.88 |
10:01 ET | 14092 | 18.965 |
10:03 ET | 9688 | 18.845 |
10:06 ET | 7871 | 18.88 |
10:08 ET | 27892 | 18.76 |
10:10 ET | 9716 | 18.82 |
10:12 ET | 2900 | 18.874 |
10:14 ET | 3769 | 18.8074 |
10:15 ET | 4590 | 18.82 |
10:17 ET | 3826 | 18.835 |
10:19 ET | 8244 | 18.84 |
10:21 ET | 4996 | 18.825 |
10:24 ET | 7400 | 18.8234 |
10:26 ET | 2247 | 18.835 |
10:28 ET | 30412 | 18.9 |
10:30 ET | 3185 | 18.84 |
10:32 ET | 2437 | 18.835 |
10:33 ET | 6894 | 18.86 |
10:35 ET | 4328 | 18.83 |
10:37 ET | 3557 | 18.85 |
10:39 ET | 7548 | 18.8001 |
10:42 ET | 5072 | 18.7312 |
10:44 ET | 2239 | 18.735 |
10:46 ET | 2140 | 18.725 |
10:48 ET | 9872 | 18.71 |
10:50 ET | 2100 | 18.705 |
10:51 ET | 5585 | 18.705 |
10:53 ET | 7453 | 18.605 |
10:55 ET | 22408 | 18.6618 |
10:57 ET | 10111 | 18.65 |
11:00 ET | 5390 | 18.57 |
11:02 ET | 12947 | 18.56 |
11:04 ET | 11927 | 18.57 |
11:06 ET | 9601 | 18.57 |
11:08 ET | 7290 | 18.605 |
11:09 ET | 10076 | 18.6184 |
11:11 ET | 12705 | 18.63 |
11:13 ET | 12163 | 18.53 |
11:15 ET | 4315 | 18.57 |
11:18 ET | 3871 | 18.5318 |
11:20 ET | 9331 | 18.5111 |
11:22 ET | 10418 | 18.52 |
11:24 ET | 5292 | 18.525 |
11:26 ET | 3253 | 18.528 |
11:27 ET | 26064 | 18.45 |
11:29 ET | 1100 | 18.42 |
11:31 ET | 49592 | 18.2018 |
11:33 ET | 18325 | 18.24 |
11:36 ET | 3144 | 18.32 |
11:38 ET | 5027 | 18.3167 |
11:40 ET | 8827 | 18.34 |
11:42 ET | 6244 | 18.37 |
11:44 ET | 2732 | 18.375 |
11:45 ET | 4824 | 18.37 |
11:47 ET | 7795 | 18.33 |
11:49 ET | 4428 | 18.31 |
11:51 ET | 16512 | 18.252 |
11:54 ET | 4581 | 18.23 |
11:56 ET | 6777 | 18.265 |
11:58 ET | 1444 | 18.26 |
12:00 ET | 1150 | 18.26 |
12:02 ET | 2013 | 18.27 |
12:03 ET | 9642 | 18.28 |
12:05 ET | 1400 | 18.265 |
12:07 ET | 1250 | 18.255 |
12:09 ET | 1666 | 18.255 |
12:12 ET | 2188 | 18.2501 |
12:14 ET | 900 | 18.2511 |
12:16 ET | 9859 | 18.298 |
12:18 ET | 2344 | 18.305 |
12:20 ET | 1339 | 18.32 |
12:21 ET | 7797 | 18.31 |
12:23 ET | 7848 | 18.3 |
12:25 ET | 3184 | 18.305 |
12:27 ET | 8404 | 18.29 |
12:30 ET | 1150 | 18.285 |
12:32 ET | 1300 | 18.2814 |
12:34 ET | 1686 | 18.2852 |
12:36 ET | 2615 | 18.2501 |
12:38 ET | 1400 | 18.24 |
12:39 ET | 2996 | 18.2201 |
12:41 ET | 873 | 18.225 |
12:43 ET | 2995 | 18.2231 |
12:45 ET | 600 | 18.229 |
12:48 ET | 7779 | 18.21 |
12:50 ET | 1291 | 18.21 |
12:52 ET | 800 | 18.215 |
12:54 ET | 1628 | 18.215 |
12:56 ET | 26325 | 18.11 |
12:57 ET | 5720 | 18.12 |
12:59 ET | 4129 | 18.16 |
01:01 ET | 3266 | 18.18 |
01:03 ET | 6676 | 18.205 |
01:06 ET | 3075 | 18.17 |
01:08 ET | 2509 | 18.1992 |
01:10 ET | 2250 | 18.195 |
01:12 ET | 5201 | 18.205 |
01:14 ET | 3966 | 18.1691 |
01:15 ET | 1885 | 18.155 |
01:17 ET | 6466 | 18.18 |
01:19 ET | 10692 | 18.2074 |
01:21 ET | 300 | 18.199 |
01:24 ET | 18356 | 18.29 |
01:26 ET | 8647 | 18.25 |
01:28 ET | 2736 | 18.25 |
01:30 ET | 3260 | 18.3 |
01:32 ET | 4236 | 18.33 |
01:33 ET | 500 | 18.3213 |
01:35 ET | 5190 | 18.335 |
01:37 ET | 8434 | 18.28 |
01:39 ET | 4821 | 18.39 |
01:42 ET | 1736 | 18.375 |
01:44 ET | 2492 | 18.39 |
01:46 ET | 3920 | 18.355 |
01:48 ET | 1632 | 18.36 |
01:50 ET | 7491 | 18.37 |
01:51 ET | 4336 | 18.37 |
01:53 ET | 152 | 18.3699 |
01:55 ET | 1500 | 18.375 |
01:57 ET | 1539 | 18.375 |
02:00 ET | 4250 | 18.375 |
02:02 ET | 1124 | 18.37 |
02:04 ET | 36208 | 18.2644 |
02:06 ET | 200 | 18.2601 |
02:08 ET | 5122 | 18.231898 |
02:09 ET | 1450 | 18.23 |
02:11 ET | 9570 | 18.23 |
02:13 ET | 13504 | 18.19 |
02:15 ET | 4366 | 18.19 |
02:18 ET | 1498 | 18.17 |
02:20 ET | 10173 | 18.1599 |
02:22 ET | 2131 | 18.145 |
02:24 ET | 7711 | 18.115 |
02:26 ET | 9333 | 18.1375 |
02:27 ET | 7051 | 18.1729 |
02:29 ET | 1340 | 18.17 |
02:31 ET | 8490 | 18.2326 |
02:33 ET | 2592 | 18.24 |
02:36 ET | 7527 | 18.2 |
02:38 ET | 2000 | 18.21 |
02:40 ET | 4417 | 18.1994 |
02:42 ET | 6494 | 18.199 |
02:44 ET | 4606 | 18.195 |
02:45 ET | 6678 | 18.2 |
02:47 ET | 4098 | 18.1925 |
02:49 ET | 18106 | 18.2 |
02:51 ET | 1624 | 18.19 |
02:54 ET | 2102 | 18.175 |
02:56 ET | 5856 | 18.165 |
02:58 ET | 2762 | 18.155 |
03:00 ET | 2387 | 18.155 |
03:02 ET | 3228 | 18.155 |
03:03 ET | 9923 | 18.16 |
03:05 ET | 5694 | 18.155 |
03:07 ET | 13611 | 18.19 |
03:09 ET | 5863 | 18.25 |
03:12 ET | 3961 | 18.27 |
03:14 ET | 10544 | 18.3 |
03:16 ET | 18781 | 18.42 |
03:18 ET | 7184 | 18.51 |
03:20 ET | 1752 | 18.515 |
03:21 ET | 6314 | 18.515 |
03:23 ET | 15158 | 18.47 |
03:25 ET | 5150 | 18.3703 |
03:27 ET | 5103 | 18.5 |
03:30 ET | 14240 | 18.51 |
03:32 ET | 6163 | 18.5701 |
03:34 ET | 9729 | 18.5132 |
03:36 ET | 4778 | 18.53 |
03:38 ET | 4719 | 18.5101 |
03:39 ET | 11436 | 18.485 |
03:41 ET | 9446 | 18.39 |
03:43 ET | 1250 | 18.425 |
03:45 ET | 5893 | 18.45 |
03:48 ET | 16569 | 18.3434 |
03:50 ET | 14187 | 18.39 |
03:52 ET | 8652 | 18.4 |
03:54 ET | 7747 | 18.4001 |
03:56 ET | 38014 | 18.59 |
03:57 ET | 8615 | 18.615 |
03:59 ET | 341553 | 18.59 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Summit Therapeutics Inc | 13.7B | -80.9x | --- |
Vaxcyte Inc | 14.1B | -23.0x | --- |
Insmed Inc | 12.1B | -12.5x | --- |
Revolution Medicines Inc | 8.4B | -14.7x | --- |
Viking Therapeutics Inc | 8.0B | -77.4x | --- |
Legend Biotech Corp | 8.2B | -28.7x | --- |
Summit Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of patient, physician and caregiver medicinal therapies. The Company's development candidate is ivonescimab, a potential first-in-class bispecific antibody intending to combine the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects of an anti-VEGF compound into a single molecule. It develops ivonescimab in non-small cell lung cancer (NSCLC), specifically launching Phase III clinical trials in the indications such as ivonescimab combined with chemotherapy in patients with epidermal growth factor receptor (EGFR)-mutated, locally advanced or metastatic non-squamous NSCLC who have progressed after treatment with a third-generation EGFR tyrosine kinase inhibitor (HARMONi), and ivonescimab combined with chemotherapy in first-line metastatic squamous NSCLC patients (HARMONi-3). Its ivonescimab is engineered with Akeso's Tetrabody technology.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $13.7B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 735.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.96 |
EPS | $-0.23 |
Book Value | $0.11 |
P/E Ratio | -80.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.